Development of a Predictive Outcome Model for Patients With Degenerative Cervical Myelopathy Using Objective Functional and Biological Measures.
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 245
- 试验地点
- 1
- 主要终点
- Data comparison between DCM and control groups
研究概览
简要总结
To create a research repository of patients with known degenerative cervical myelopathy (DCM) and a control cohort of subjects who have non-myelopathic spinal disease. This repository will be used to assess functional and/or biological measures that may allow for improved prediction of symptomatic progression and response to treatment in patients with DCM. In addition, this repository will be used to develop a risk assessment scale to accurately predict functional outcomes following operative management of DCM.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of degenerative cervical myelopathy
- •Diagnosis of cervical degenerative disease without myelopathy
排除标准
- •None outside or diagnostic requirements and age limits.
研究组 & 干预措施
DCM group
Subjects diagnosed with degenerative cervical myelopathy.
干预措施: Standard clinical care procedures and outcome measurements. (Other)
Control group
Subjects diagnosed with cervical spinal disease without myelopathic symptoms.
干预措施: Standard clinical care procedures and outcome measurements. (Other)
结局指标
主要结局
Data comparison between DCM and control groups
时间窗: 2 years
This study is to determine biomarkers associated with DCM and analyze objective clinical measures to determine more predictable and potentially effective treatments for patients diagnosed with cervical myelopathy.
次要结局
未报告次要终点
研究者
Francis Farhadi
Associate Professor
University of Kentucky